These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 16049620

  • 1. Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma.
    Kim SJ, Seo HY, Choi JG, Sul HR, Sung HJ, Park KH, Choi IK, Oh SC, Yoon SY, Seo JH, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS.
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):436-42. PubMed ID: 16049620
    [Abstract] [Full Text] [Related]

  • 2. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT, Yoon SY, Shin SW, Kim BS, Mok YJ, Kim CS, Hyun JH, Kim JS, Kim YH.
    Cancer; 2001 Jun 15; 91(12):2288-93. PubMed ID: 11413517
    [Abstract] [Full Text] [Related]

  • 3. Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
    Idelevich E, Karminsky N, Dinerman M, Katsenelson RL, Zvi NB, Baruch NB, Biran H, Man S, Shani A.
    Acta Oncol; 2007 Jun 15; 46(3):324-9. PubMed ID: 17450467
    [Abstract] [Full Text] [Related]

  • 4. The efficacy of epirubicin, cisplatin, uracil/tegafur, and leucovorin in patients with advanced biliary tract carcinoma.
    Park KH, Choi IK, Kim SJ, Oh SC, Seo JH, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS.
    Cancer; 2005 Jun 01; 103(11):2338-43. PubMed ID: 15825161
    [Abstract] [Full Text] [Related]

  • 5. Epirubicin, cisplatin, oral UFT, and calcium folinate in advanced gastric carcinoma.
    Kim YH, Kim BS, Seo JH, Choi CW, Kim JS, Chun HJ, Hyun JH, Kim JS.
    Oncology (Williston Park); 1999 Jul 01; 13(7 Suppl 3):64-8. PubMed ID: 10442365
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and toxicity of lower dose UFT without leucovorin in metastatic gastric cancer patients.
    Somali I, Meydan N, Tarhan MO, Oztop I, Alacacioglu A, Yilmaz U.
    J BUON; 2009 Jul 01; 14(3):429-33. PubMed ID: 19810134
    [Abstract] [Full Text] [Related]

  • 7. A phase II trial. Oral UFT and leucovorin in patients with advanced gastric carcinoma.
    Kim YH, Shin SW, Kim BS, Park YT, Kim JG, Kim JS.
    Oncology (Williston Park); 1997 Sep 01; 11(9 Suppl 10):119-23. PubMed ID: 9348583
    [Abstract] [Full Text] [Related]

  • 8. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J, González Barón M, García-Girón C, Espinosa E, García-Alfonso P, Belón J, Blanco E, Garrido P, Ordónez A, Gómez-Navarro J, Zamora P.
    Cancer; 1996 Jul 15; 78(2):211-6. PubMed ID: 8673994
    [Abstract] [Full Text] [Related]

  • 9. Epirubicin, cisplatin, oral UFT, and leucovorin combination chemotherapy in advanced and metastatic esophageal cancer.
    Choi IK, Seo HY, Sung HJ, Park KH, Kim SJ, Oh SC, Seo JH, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS.
    Med Oncol; 2007 Jul 15; 24(1):33-7. PubMed ID: 17673809
    [Abstract] [Full Text] [Related]

  • 10. A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
    Woo IS, Moon DH, Shim BY, Lee MA, Byun JH, Kim KW, Kang JH, Choi MG, Chung IS, Hong YS, Park SY, Lee KS.
    Jpn J Clin Oncol; 2005 Jan 15; 35(1):13-7. PubMed ID: 15681598
    [Abstract] [Full Text] [Related]

  • 11. The UFT/leucovorin/etoposide regimen for the treatment of advanced gastric cancer. Oncopaz Cooperative Group.
    González Barón M, Espinosa E, Feliu J, Ordóñez A, Zamora P, de Castro J, García Girón C, García Alfonso P, Garrido P, Belón J, Lomas M.
    Oncology (Williston Park); 1997 Sep 15; 11(9 Suppl 10):109-12. PubMed ID: 9348581
    [Abstract] [Full Text] [Related]

  • 12. A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinoma.
    Zhu AX, Fuchs CS, Clark JW, Muzikansky A, Taylor K, Sheehan S, Tam K, Yung E, Kulke MH, Ryan DP.
    Oncologist; 2005 Sep 15; 10(6):392-8. PubMed ID: 15967833
    [Abstract] [Full Text] [Related]

  • 13. Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced hepatocellular carcinoma.
    Mani S, Schiano T, Garcia JC, Ansari RH, Samuels B, Sciortino DF, Tembe S, Shulman KL, Baker A, Benner SE, Vokes EE.
    Invest New Drugs; 2005 Sep 15; 16(3):279-83. PubMed ID: 10360610
    [Abstract] [Full Text] [Related]

  • 14. Phase II trial of Oral UFT and leucovorin in advanced gastric carcinoma.
    Kim YH, Cheong SK, Lee JD, Park JS, Shin SW, Kim JS.
    Am J Clin Oncol; 1996 Apr 15; 19(2):212-6. PubMed ID: 8610653
    [Abstract] [Full Text] [Related]

  • 15. UFT/leucovorin plus irinotecan in advanced or metastatic colorectal cancer.
    Price T, Hill M.
    Oncology (Williston Park); 2000 Oct 15; 14(10 Suppl 9):28-31. PubMed ID: 11098487
    [Abstract] [Full Text] [Related]

  • 16. Epirubicin, cisplatin and oral UFT with leucovorin ('ECU'): a phase I-II study in patients with advanced upper gastrointestinal tract cancer.
    Seymour MT, Dent JT, Papamichael D, Wilson G, Cresswell H, Slevin ML.
    Ann Oncol; 1999 Nov 15; 10(11):1329-33. PubMed ID: 10631461
    [Abstract] [Full Text] [Related]

  • 17. Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancer.
    Veronese ML, Stevenson JP, Sun W, Redlinger M, Algazy K, Giantonio B, Hahn S, Vaughn D, Thorn C, Whitehead AS, Haller DG, O'Dwyer PJ.
    Eur J Cancer; 2004 Mar 15; 40(4):508-14. PubMed ID: 14962716
    [Abstract] [Full Text] [Related]

  • 18. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
    Tsutsumi S, Yamaguchi S, Tsuboi K, Fukasawa T, Tabe Y, Asao T, Kuwano H.
    Hepatogastroenterology; 2008 Mar 15; 55(85):1419-22. PubMed ID: 18795703
    [Abstract] [Full Text] [Related]

  • 19. UFT/leucovorin plus bolus epirubicin and cyclophosphamide in advanced/metastatic breast cancer.
    Gregory RK, Johnston SR, Smith IE, Miles D.
    Oncology (Williston Park); 2000 Oct 15; 14(10 Suppl 9):47-9. PubMed ID: 11098493
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.